Literature DB >> 15958607

Getting at MYC through RAS.

Pavan Bachireddy1, Pavan K Bendapudi, Dean W Felsher.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15958607     DOI： 10.1158/1078-0432.CCR-05-0534

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  16 in total

Review 1.  An intermittent approach for cancer chemoprevention.

Authors:  Xiangwei Wu; Scott M Lippman
Journal:  Nat Rev Cancer       Date:  2011-11-10       Impact factor: 60.716

2.  MEK/ERK inhibitor U0126 increases the radiosensitivity of rhabdomyosarcoma cells in vitro and in vivo by downregulating growth and DNA repair signals.

Authors:  Francesco Marampon; Giovanni Luca Gravina; Agnese Di Rocco; Pierluigi Bonfili; Mario Di Staso; Caterina Fardella; Lorella Polidoro; Carmela Ciccarelli; Claudio Festuccia; Vladimir M Popov; Richard G Pestell; Vincenzo Tombolini; Bianca Maria Zani
Journal:  Mol Cancer Ther       Date:  2011-01       Impact factor: 6.261

Review 3.  Histological complexities of pancreatic lesions from transgenic mouse models are consistent with biological and morphological heterogeneity of human pancreatic cancer.

Authors:  J D Liao; N V Adsay; F Khannani; D Grignon; A Thakur; F H Sarkar
Journal:  Histol Histopathol       Date:  2007-06       Impact factor: 2.303

4.  MYC levels govern hematopoietic tumor type and latency in transgenic mice.

Authors:  Darrin P Smith; Mary L Bath; Donald Metcalf; Alan W Harris; Suzanne Cory
Journal:  Blood       Date:  2006-03-14       Impact factor: 22.113

5.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

6.  Molecular Genetic Analysis of Ovarian Brenner Tumors and Associated Mucinous Epithelial Neoplasms: High Variant Concordance and Identification of Mutually Exclusive RAS Driver Mutations and MYC Amplification.

Authors:  Laura J Tafe; Kristen E Muller; Guruprasad Ananda; Talia Mitchell; Vanessa Spotlow; Sara E Patterson; Gregory J Tsongalis; Susan M Mockus
Journal:  Am J Pathol       Date:  2016-01-18       Impact factor: 4.307

Review 7.  MYC degradation.

Authors:  Amy S Farrell; Rosalie C Sears
Journal:  Cold Spring Harb Perspect Med       Date:  2014-03-01       Impact factor: 6.915

8.  Direct Phosphorylation and Stabilization of MYC by Aurora B Kinase Promote T-cell Leukemogenesis.

Authors:  Jue Jiang; Jingchao Wang; Ming Yue; Xiaolian Cai; Tianci Wang; Chao Wu; Hexiu Su; Yanwu Wang; Meng Han; Yingchi Zhang; Xiaofan Zhu; Peng Jiang; Peng Li; Yonghua Sun; Wuhan Xiao; Hui Feng; Guoliang Qing; Hudan Liu
Journal:  Cancer Cell       Date:  2020-02-10       Impact factor: 31.743

9.  Cyclophilin B supports Myc and mutant p53-dependent survival of glioblastoma multiforme cells.

Authors:  Jae Won Choi; Mark A Schroeder; Jann N Sarkaria; Richard J Bram
Journal:  Cancer Res       Date:  2013-11-22       Impact factor: 12.701

Review 10.  Murine models and cell lines for the investigation of pheochromocytoma: applications for future therapies?

Authors:  Esther Korpershoek; Karel Pacak; Lucia Martiniova
Journal:  Endocr Pathol       Date:  2012-03       Impact factor: 3.943
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.